glaucoma drainage devices market size, glaucoma drainage devices market growth, glaucoma drainage devices market forecast, glaucoma drainage devices market segments, glaucoma drainage devices market, glaucoma drainage devices market demand
What are the latest figures on the glaucoma drainage devices market’s size and projected CAGR?
The glaucoma drainage devices market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.90 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of diabetes, increasing geriatric population, increasing number of hospitals, and rising government initiatives and disposable income.
The glaucoma drainage devices market size is expected to see rapid growth in the next few years. It will grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the increasing prevalence of glaucoma conditions, increasing clinical trials, increasing healthcare expenditure, increasing personalized treatment, and increasing lifestyle disorders. Major trends in the forecast period include advancement in minimally invasive glaucoma surgery, microstents and nanotechnology innovations, advancements in biocompatible materials, and a rising trend toward combining glaucoma drainage devices and adjustable and refillable drainage systems.
Get Your Free Sample of The Global Glaucoma Drainage Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20821&type=smp
Which Market drivers have played a significant role in driving the glaucoma drainage devices market?
The increasing prevalence of glaucoma conditions is expected to propel the growth of the glaucoma drainage devices market going forward. Glaucoma encompasses a group of eye disorders that damage the optic nerve, typically due to increased intraocular pressure, potentially resulting in vision loss if not addressed. The rising cases of glaucoma can be attributed to several factors, such as an aging population, urbanization, and lifestyle changes. Glaucoma drainage devices help manage intraocular pressure in refractory glaucoma by facilitating aqueous humor outflow when conventional treatments fail. For instance, in March 2022, according to the Glaucoma Research Foundation, a US-based innovative research foundation, as of 2022, approximately 80 million individuals globally are affected by glaucoma, with an alarming estimate indicating that nearly half of these individuals remain unaware of their condition. In the United States alone, over 3 million citizens suffer from glaucoma, with a similar proportion of undiagnosed cases. Therefore, the increasing prevalence of glaucoma conditions is driving the growth of the glaucoma drainage devices market.
What are the key segments within the glaucoma drainage devices market?
The glaucoma drainage devices market covered in this report is segmented –
1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices
2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others
2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/glaucoma-drainage-devices-global-market-report
Which key players are shaping the glaucoma drainage devices market?
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical
Which transformative trends will shape the glaucoma drainage devices market landscape?
Major companies operating in the glaucoma drainage devices market are focusing on developing next-generation canal-based glaucoma surgery devices to offer minimally invasive options and address the growing demand for safer, more efficient treatments. Canal-based glaucoma surgery devices are implants that target the Schlemm’s canal to enhance aqueous humor drainage, reducing intraocular pressure (IOP). This helps manage glaucoma by addressing the primary cause of the condition’s progression. For instance, in March 2023, Nova Eye Medical Limited, an Australia-based glaucoma devices manufacturer, received clearance for its iTrack Advance canaloplasty device. This innovative device is engineered for microcatheterization and viscodilation to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma. The iTrack Advance is equipped with an ergonomic handpiece and enhanced technology to improve surgical efficiency. It is designed for both standalone procedures and those performed in conjunction with cataract surgery.
How do regional factors impact the glaucoma drainage devices market, and which region is the largest contributor?
North America was the largest region in the glaucoma drainage devices market in 2024. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Glaucoma Drainage Devices Market Report 2025 Offer?
The glaucoma drainage devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Glaucoma drainage devices are surgical implants designed to reduce intraocular pressure in patients with glaucoma. These devices provide a controlled outflow of aqueous humor from the eye, helping to prevent optic nerve damage. They are typically used when other treatments, such as medication or laser therapy, are insufficient.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20821
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
